For the convenience of treatment, Shen Guohua was transferred from Modu Ruijin Hospital to Sanbo Research Institute, with Dr. Li accompanying him to the institute.
Five days later, treatment began.
Shen Guohua had already signed the 12-page informed consent form, with three pages specifically explaining the experimental nature of the new vector. His eyes were calm, even with a peculiar sense of relief, at least he was fighting to live, rather than passively waiting for death; for a terminal patient, hope, even a sliver, is extremely important.
Yang Ping had Dr. Li treat Shen Guohua, as he was his patient. In the ward, everyone was on high alert.
"Mr. Shen, we are about to start," Dr. Li said, "The process is just like a normal infusion, about twenty minutes. After that, you may have fever, chills, and muscle aches, which are side effects of the medication, and we have experience dealing with these side effects; they are controllable."
